NCT04856631 2022-12-19
A Study of Toripalimab Injection (JS001) + Cetuximab in Treatment of Advanced Head and Neck Squamous Cell Cancer
Shanghai Junshi Bioscience Co., Ltd.
Phase 1/2 Unknown
Shanghai Junshi Bioscience Co., Ltd.
ChineseAMS
Jiangsu Cancer Institute & Hospital
Helsinki University Central Hospital